Nundina › Kalender entdecken › FDA-Zulassungen neuer Arzneimittel-Kalender › FDA approves Bexlutry (lutetium lu-177 dotatate)FDA approves Bexlutry (lutetium lu-177 dotatate)14. September 2026The FDA approved Bexlutry (lutetium lu-177 dotatate), a drug from Curium. Form: Solution, Intravenous. Application NDA218525.FDA-Zulassungen neuer Arzneimittel-KalenderMehr aus diesem Kalender